GSK in HIV drug deal with Shionogi
GlaxoSmithKline has beefed up its interest in an HIV drug which analysts regard as a potential multi-billion-dollar-a-year blockbuster.
A new deal with Shionogi sees Britain's biggest pharmaceuticals company give the Japanese drug maker a 10 per cent stake in Viiv Healthcare – an HIV drug joint venture set up in 2009 between GSK and Pfizer – in exchange for its rights to dolutegravir, a once-daily HIV medicine hich has performed well in clinical trials.
Previously, income from the medicine would have been shared 50/50 between Viiv and Shionogi, where now GSK will earn as much as 66 per cent from the drug.
- 1 Rarest Beanie Baby bought for just £10 at car boot sale could be sold for £62,500 on eBay
- 3 Parma, Missouri: 80 per cent of town's police quit after first black mayor is elected
- 5 Google search history can now be downloaded in its entirety, mass embarrassment expected
Rarest Beanie Baby bought for just £10 at car boot sale could be sold for £62,500 on eBay
Katie Hopkins and The Sun editor David Dinsmore reported to police for incitement to racial hatred following migrant boat column
'Jihadi John': Isis executioner Mohammed Emwazi wanted to wage jihad in Somalia until his friends were betrayed and killed by al-Shabaab
Parma, Missouri: 80 per cent of town's police quit after first black mayor is elected
Australian student Tommy Connolly, 23, adopts his pregnant, homeless 17-year-old cousin to give her a chance at 'a better life'
If I’m being racially abused I don’t need a stranger with a saviour complex to rescue me
The only black face in the Ukip manifesto is on the page about overseas aid
Ukip is the only main political party to not address LGBT rights in its manifesto
Food banks: One million Britons will soon be using them, according to Trussell Trust
Religion isn't growing, it is becoming vigorous in its demise, says philosopher AC Grayling
BBC election debate: The one photo that summed up the whole 90-minute leaders debate
iJobs Money & Business
£60000 - £70000 per annum + benefits : Ashdown Group: A highly successful, glo...
£30 - 35k (DOE): Guru Careers: We are seeking a Pricing Analyst with experienc...
£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...
£21000 - £24000 per annum: Ashdown Group: The Ashdown Group has been engaged b...